Congenital rubella syndrome: progress and future challenges

References

• Gregg NM. Congenital cataract following German measles in the mother. Aust NZ J. Ophthalmol.3, 35–46 (1941).
   Google Scholar
• Banatvala JE, Brown DWG. Rubella. Lancet363, 1127–1137 (2004).
   PubMed Web of Science ®Google Scholar
• Grillner L, Forsgren M, Barr B, Boottiger M, Danielsson L, Verdier C. Outcome of rubella during pregnancy with special reference to the 17th–24th weeks of gestation. Scand. J. Infect. Dis.15, 321–325 (1983).
   PubMed Web of Science ®Google Scholar
• Weller TH, Neva FA. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc. Soc. Exp. Biol. Med.111, 225–230 (1962).
   Google Scholar
• Bhate S, Kanvinde S, Mankar S, Phadke MA. Evaluation of efficacy of MMR vaccine in India. Conference Abstracts India (1994).
   Google Scholar
• Centers for Disease Control and Prevention: nationwide campaign for vaccination of adults against rubella and measles Costa Rica 2001. MMWR Morb. Mort. Wkly Rep.150, 976–979 (2001).
   Google Scholar
• Preblud SR, Serdula MK, Frank JA, Branding-Bennett DA, Hinman AR. Rubella vaccination in the United States: a ten year review. Epidemiol. Rev.2, 171–194 (1980).
   PubMedGoogle Scholar
• Orenstein WA, Bart KJ, Hinman AR et al. The opportunity and obligation to eliminate rubella from the United States. JAMA251, 1988–1994 (1984).
   PubMed Web of Science ®Google Scholar
• Reef SE, Frey TK, Theall K et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA287, 464–472 (2002).
   Google Scholar
• Reef SE, Plotkin S, Cordero JF et al. Preparing for elimination of congenital rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin. Infect. Dis.31, 85–95 (2000).
   PubMed Web of Science ®Google Scholar
• Cheffins T, Chan A, Keane RJ, Haan EA, Hall R. The impact of rubella immunisation on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia. Br. J. Obstetr. Gynecol.105, 998–1004 (1998).
   Google Scholar
• Farber ME, Finkelstein SN. A cost–benefit analysis of a mandatory premarital rubella-antibody screening program. N. Engl. J. Med.300, 856–859 (1979).
   Google Scholar
• Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J. Infect. Dis.187(Suppl. 1), S146–S152 (2003).
   Google Scholar
• Kelly H, Worth L, Karapanagiotidis T, Riddell M. Interruption of rubella virus transmission in Australia may require vaccination of adults males: evidence from a Victorian sero-survey. Commun. Dis. Intel.28, 69–73 (2004).
   Google Scholar
• Villarejos VM, Arguedas-Gamboa JA, Vargas-Naar O, Cortés-Vargas MA. Study of the effectiveness and safety of rubella vaccine.Bol. Oficina Sanit. Panam.70, 174–180 (1971).
   Google Scholar
• Morice A, González L, Castillo-Solórzano C. Tendencias de la inmunidad a la rubéola en mujeres de edad fértil y pre-escolares en Costa Rica, 1969–1996. Acta. Pediatr. Costarr.19, 13–18 (2005).
   Google Scholar
• Morice A, Carvajal X, León M et al. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience. J. Infect. Dis.187(Suppl. 1), 158–163 (2003).
   Google Scholar
• Avila-Agüero ML, Morice A, Castillo-Solórzano C et al. Síndrome de rubéola congénita en Costa Rica: importancia de la vigilancia activa. An. Pediatr. (Barc.)62, 43–47 (2005).
   Google Scholar
• Jiménez G, Avila-Aguero ML, Morice A et al. Estimating the burden of congenital rubella syndrome in Costa Rica, 1996–2001. Pediatr. Infect. Dis. J.26, 382–386 (2007).
   Google Scholar
• Badilla X, Morice A, Sáenz E et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr. Infect. Dis. J.26, 830–835 (2007).
   PubMedGoogle Scholar
• Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am. J. Clin. Genetics130, 52–54 (2004).
   Google Scholar
• Centers for Disease Control and Prevention: Revised ACIP recommendation for avoiding pregnancy after reviewing a rubella-containing vaccine. MMWR Morb. Mort. Wkly Rep.50, 1117 (2001).
   PubMedGoogle Scholar
• Enders G. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccinations during pregnancy. Rev. Infect. Dis.7(Suppl. 1), 5103–5107 (1985).
   Google Scholar
• Centers for Disease Control and Prevention: Measles, mumps and rubella vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps. Recommendation of the Advisory Committee on Immunization Practices. MMWR Morb. Mort. Wkly Rep.47(8), 1–57 (1998).
   PubMedGoogle Scholar
• Anderson RM, May RM. Vacination against rubella and measles: quantitative investigations of different policies. J. Hygiene (Lond.),90, 259–325 (1983).
   PubMedGoogle Scholar
• Horstmann DM, Riordan JT, Ohtawara M, Niederman JC. A natural epidemic of rubella in a closed population: virological and epidemiological observations. Arch. Ges. Virusforsch.16, 483–487 (1965).
   PubMedGoogle Scholar
• Mellinger AK, Cragan JD, Atkinson WL et al. High incidence of congenital rubella syndrome after a rubella outbreak. Pediatr. Infect. Dis. J.14, 573–578 (1995).
   Google Scholar
• Greaves WL, Orenstein WA, Hinman AR, Nersesian WS. Clinical efficacy of rubella vaccine. Pediatr. Infect. Dis.2, 284–286 (1983).
   Google Scholar
• Balfour HH, Groth KE, Edelman CK. RA27/3 rubella vaccine. Am. J. Dis. Child.134, 350–353 (1990).
   Google Scholar
• Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15 year follow-up in Finland. Vaccine18, 3106–3112 (2000).
   PubMed Web of Science ®Google Scholar
• Balfour HH, Groth KE, Edelman CK, Amren DP, Best JM, Banatvala JE. Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet1, 1078–1080 (1981).
   PubMed Web of Science ®Google Scholar
• Plotkin SA, Orenstein WA. Rubella vaccine. In: Vaccines (4th Edition). Elsevier Inc., PA, USA 707–743 (2004).
   Google Scholar
• Sterh-Green PA, Cochi SL, Preblud SR, Orenstein WA. Evidence against increasing rubella seronegativity among adolescent girls. Am. J. Public Health80(1), 88 (1990).
   Google Scholar
• Rafnar B. Rubella immunization of teenage girls in Iceland and follow-up after severe rubella epidemic. Bull. World Health Organ.60, 141–146 (1980).
   Google Scholar
• Gale JL, Detels R, Kim KSW, Beasley RP, Chen KP, Grayston T. The epidemiology of rubella on Taiwan. III. Family studies in cities of high and low attack rates. Int. J. Epidemiol.1, 261–265 (1972).
   Google Scholar
• Brody JA, Sever JL, Mc Alisiter R, Schiff GM, Cutting R. Rubella epidemic on St Paul Island in the Pribilofs, 1963. JAMA191, 619–623 (1965).
   PubMed Web of Science ®Google Scholar
• CDC. Rubella and congenital rubella syndrome – United States 1984–1985. MMWR Morb. Mort. Wkly Rep.35, 129–135 (1986).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Update on Adult Immunization Recommendation Practices Advisory Committee (ACIP). MMWR Morb. Mort. Wkly Rep.40(12), 1–52 (1991).
   PubMedGoogle Scholar
• Reef SE, Cochi SL. The evidence for elimination of rubella and congenital rubella syndrome in the United States: a public health achievement. Clin. Infect. Dis.43(Suppl. 3), S123–S125 (2006).
   Google Scholar
• Terada K. Rubella and congenital rubella syndrome in Japan: epidemiological problems. Jpn J. Infect. Dis.56, 81–87 (2003).
   PubMed Web of Science ®Google Scholar
• Schtzmayr HG. Aspects of rubella infection in Brazil. Rev. Infect. Dis.7(Suppl. 1), S53–S55 (1985).
   Google Scholar
• Galazka A. Rubella in Europe. Epidemiol. Infect.107, 43–54 (1991).
   PubMed Web of Science ®Google Scholar
• Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunization in Greece: retrospective survey and systematic review. BMJ319, 1462–1465 (1999).
   PubMed Web of Science ®Google Scholar
• Castillo-Solórzano de Quadros CE. Accelerated rubella control and the prevention of congenital rubella syndrome. Rev. Panam. Salud Publica11, 273–276 (2002).
   Google Scholar
• Schuler WW, Reef S, Redd SC, Dykewicz CA. Changing epidemiology of congenital rubella syndrome in the United States. J. Infect. Dis.178, 636–641 (1998).
   Google Scholar
• Centers for Disease Control and Prevention. Progress toward elimination of rubella and congenital rubella syndrome – the Americas, 2003–2008. MMWR Morb. Mort. Wkly Rep.57, 1176–1179 (2008).
   Google Scholar